PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-13.72%
Revenue decline while CRWV shows 23.55% growth. Joel Greenblatt would examine competitive position erosion.
-21.78%
Cost reduction while CRWV shows 19.16% growth. Joel Greenblatt would examine competitive advantage.
-8.01%
Gross profit decline while CRWV shows 25.15% growth. Joel Greenblatt would examine competitive position.
6.62%
Margin expansion exceeding 1.5x CRWV's 1.30%. David Dodd would verify competitive advantages.
2.76%
R&D change of 2.76% while CRWV maintains spending. Bruce Berkowitz would investigate effectiveness.
9.83%
G&A growth while CRWV reduces overhead. John Neff would investigate operational differences.
-13.99%
Marketing expense reduction while CRWV shows 248.84% growth. Joel Greenblatt would examine competitive risk.
-250.00%
Other expenses reduction while CRWV shows 19.33% growth. Joel Greenblatt would examine efficiency.
-4.71%
Operating expenses reduction while CRWV shows 17.97% growth. Joel Greenblatt would examine advantage.
-14.19%
Total costs reduction while CRWV shows 18.28% growth. Joel Greenblatt would examine advantage.
10.03%
Interest expense growth above 1.5x CRWV's 1.19%. Michael Burry would check for over-leverage.
10.56%
D&A growth less than half of CRWV's 26.15%. David Dodd would verify if efficiency is sustainable.
-12.33%
EBITDA decline while CRWV shows 33.05% growth. Joel Greenblatt would examine position.
6.47%
Similar EBITDA margin growth to CRWV's 7.69%. Walter Schloss would investigate industry trends.
-12.33%
Operating income decline while CRWV shows 169.93% growth. Joel Greenblatt would examine position.
1.61%
Operating margin growth below 50% of CRWV's 156.60%. Michael Burry would check for structural issues.
-44.44%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
-13.99%
Pre-tax income decline while CRWV shows 9.63% growth. Joel Greenblatt would examine position.
-0.31%
Pre-tax margin decline while CRWV shows 26.86% growth. Joel Greenblatt would examine position.
52.93%
Tax expense growth above 1.5x CRWV's 3.78%. Michael Burry would check for concerning trends.
-25.15%
Net income decline while CRWV shows 7.67% growth. Joel Greenblatt would examine position.
-13.25%
Net margin decline while CRWV shows 25.27% growth. Joel Greenblatt would examine position.
-23.81%
EPS decline while CRWV shows 23.08% growth. Joel Greenblatt would examine position.
-24.19%
Diluted EPS decline while CRWV shows 23.08% growth. Joel Greenblatt would examine position.
-0.87%
Share count reduction while CRWV shows 20.32% change. Joel Greenblatt would examine strategy.
-0.82%
Diluted share reduction while CRWV shows 20.32% change. Joel Greenblatt would examine strategy.